Chiesi Focuses on Patient-Centered Care in Fabry Disease
Chiesi Global Rare Diseases has published survey results in the Orphanet Journal of Rare Diseases that [...]
Forecast of the Global Real World Evidence (RWE) Solutions Market
The Global Real World Evidence (RWE) Solutions Market is forecasted to grow from 2.7 billion (USD) [...]
Study Reveals Racial Disparities in Prostate Cancer Care
A landmark study conducted by Analysis Group has highlighted significant racial disparities in the treatment and [...]
Study Reveals Political Affiliation Influences COVID-19 Vaccine Adverse Event Reporting
A recent study published in JAMA Network Open indicates that political affiliations may significantly influence the [...]
EU Spearheads Real-World Evidence Projects to Revolutionize Healthcare Decision-Making
The European Union is in charge of integrating real-world evidence (RWE) and advanced data analytics into [...]
Pain Points Associated with Analyses of Real-World Data Sources: A Survey
To inform an upcoming ISPOR 2024 workshop, David Thompson of Rubidoux Research is fielding a brief survey to solicit [...]
GSK Advances Oligonucleotide Research with Elsie Biotechnologies Platform License
GlaxoSmithKline (GSK) has solidified its commitment to oligonucleotide therapeutics by securing a nonexclusive license to Elsie [...]
Can We Trust the Data? The Case for Validation
Real world research has produced recent newsworthy findings on topics as diverse as COVID, mental health, cancer, and dementia. [...]
Trinity Life Sciences Reports Promising Opportunities in China’s 2022 NRDL for Innovative Drugs
Trinity Life Sciences, a global life sciences solutions leader, reports promising opportunities for innovative drugs in [...]
Exploring the Potential and Challenges of mRNA Technology in Revolutionizing Flu Vaccines
The article discusses the potential of mRNA technology, popularized during the COVID-19 pandemic, in revolutionizing flu [...]
Respiratory Viruses Return to Seasonal Patterns After Covid-19 Disruption
During the height of the COVID-19 pandemic, other respiratory viruses such as the flu, RSV, and [...]
Reagan-Udall Foundation Calls for Overhaul of Post-Market Evidence Generation System, Suggests FDA-Led Approach
The Reagan-Udall Foundation asserts in a new report that the current post-market evidence generation system is [...]
FDA Issues Draft Guidance Recognizing the Role of Real-World Evidence in Learning More about Populations Underrepresented in Clinical Trials for Drugs and Biological Products
By: Ulka Campbell, Head of Scientific Strategy, Aetion Of the many potential use cases for real-world data (RWD) [...]
The Future of Diversity in Clinical Trials: Real-World Evidence
This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.
Global Real-World Data Market Forecast to Grow at 14.4% CAGR from 2023 to 2030, Fueled by Increased Demand for Evidence-based Medicine and Technological Advancements
The global real-world data (RWD) market, which encompasses data collected outside of clinical trials, is forecasted to grow at a [...]
Galecto Laying Off 70% of Staff and Exploring Strategic Alternatives after Failed Lung Disease Drug Trial
Boston-based biotech firm Galecto plans to lay off 29 employees, approximately 70% of its workforce, after [...]
Class-Action Lawsuit Targets Johnson & Johnson and IBM after Data Breach
Johnson & Johnson and IBM face a proposed class-action lawsuit following a data breach at J&J’s [...]
Higher Suicide Risk Among Health Care Workers, Especially Women: Study Reveals
A new study in the Journal of the American Medical Association suggests that health care workers, [...]
Christine Davis Appointed as New President of Ontada
Ontada, a McKesson business focusing on oncology real-world data and evidence, has appointed Christine Davis as [...]
FDA Updates Guidelines on Using Single Clinical Investigation as Confirmatory Evidence for New Drug Approval
The FDA has issued a draft guide to clarify how evidence from a sole clinical investigation [...]
Alexion Pharmaceuticals Nears $125M Settlement in Class Action Lawsuit Over Alleged Unethical Sales Practices
A 2016 class action lawsuit against pharmaceutical company Alexion, which claimed that the company's unethical sales [...]
Ongoing Medicare Privatization Will Hurt Pharma As Much As the IRA
The pharmaceutical industry is in a frenzy over the recently released list of the drugs subject to [...]
Cognitive Ability Tied to COVID-19 Vaccination Rates
The study published in the Journal of Health Economics investigated a link between an individual's cognitive [...]
AI-Enhanced Testing: Transforming the Landscape of Software Quality Assurance
Traditional test automation has limitations in replicating real-world user behavior and interactivity, which results in a need for an [...]
FDA Releases Guidance on Utilizing Real-World Evidence for Pharmaceutical Regulatory Review Process
The FDA has published final draft guidance for pharmaceutical companies, indicating how they can use real-world evidence to support their [...]